d) Oncology (Lung Cancer) at Eli Lilly and Company

Germany

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Clinical experience in thoracic oncology
Track record in medical affairs
Demonstrated experience working with thought leaders and in engagement management
Ability to convey scientific data clearly and effectively to diverse audiences
Experienced in cross-functional collaboration and working in a matrix organization
Willingness to travel internationally as needed
Experience with integration of Digital Technologies

Responsibilities

Provide clinical and scientific expertise to support all aspects of the international lung cancer business
Build and maintain meaningful relationships with lung cancer specialists and thought leaders to enhance brand and product recognition
Lead and support international Medical Affairs activities before, during, and after product launches
Collaborate closely with global and local teams and other departments to implement strategic plans and improve customer experiences
Support and conduct scientific training and education sessions for internal and external stakeholders
Plan and conduct international studies, as well as support the implementation of global clinical trials
Lead the integration of new technologies into the Oncology Business Unit

Skills

Oncology

Lung Cancer

Clinical Research

Medical Affairs

Thought Leader Engagement

Product Launch

Scientific Training

KOL Management

Cross-Functional Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free